Eluvixtamab (AMG-330)
Revision as of 01:35, 17 July 2014 by Jwarner (talk | contribs) (Created page with "=Mechanism of action= Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 Category:Investigational Category:Antibody medications")
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3